T1	Participants 682 786	Craving (VAS; OCDS), withdrawal (CIWA-Ar) and psychiatric symptoms (SCL-90-R) rating scales were applied
T2	Participants 1 31	regabalin versus naltrexone in
T3	Participants 30 96	n alcohol dependence: a randomised, double-blind, comparison trial
T4	Participants 881 1031	Compared with NAL, PRE resulted in greater improvement of specific symptoms in the areas of anxiety, hostility and psychoticism, and survival function
T5	Participants 1164 1253	sults from this study globally place PRE within the same range of efficacy as that of NAL
